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Abstract 
After nearly three decades of research, there is still no clarity on the causal relationship between 
chronic cocaine use and cognitive functioning. However, the current literature consistently suggests 
that broad cognitive impairments occur in not only dependent cocaine users but also recreational 
cocaine users, with impairments involving attention, working memory declarative memory and 
executive functions. Moreover, it was recently shown that chronic cocaine users exhibit specific 
deficits in socio-cognitive abilities, which very likely contribute to the social dysfunctions that occur 
in their daily lives. Correlation analyses and initial longitudinal studies indicate that most cognitive 
deficits are at least partially cocaine-induced. Accordingly, there is also some evidence regarding the 
recovery of cognitive functions in decreasing and long-term abstinent users.  
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Introduction 
Since cocaine dependence first appeared as a diagnostic category with the publication of the DSM-III-
R, research studies have been conducted to examine the relationship between repeated cocaine use and 
its physical, psychological and neurobiological consequences. In this context, a growing body of 
literature has consistently linked ongoing chronic cocaine use to different aspects of cognitive 
functioning. Although drug use is generally considered to be driven by positive and negative affective 
or emotional states (Koob, 2013), it also comprises a substantial volitional component based on 
cognitive processes guiding decision-making and behaviour (Garavan & Hester, 2007). Hence, it is 
important to investigate cognitive changes in cocaine users so as to attain a better understanding of the 
mechanisms of recreational and controlled cocaine use and its transition to dependent use as well as 
successful cocaine abstinence and relapse (Garavan & Hester, 2007; Gould, 2010). Moreover, as 
cognitive functioning seems to be relevant at each stage of the drug use cycle (Garavan & Hester, 
2007), drug addiction might generally be considered a disorder of altered cognition (Gould, 2010) – or 
more specifically, a form of pathological learning and memory (Hyman, 2005). Consequently, this 
raises the essential question regarding to what extent the impaired cognitive functions of cocaine users 
are pre-existent traits, drug-induced consequences or an interaction of both. The clarification of this 
issue is important with regard to not only the development of more complex addiction models but also 
the improvement of prevention, treatment and post-treatment strategies in cocaine addiction. 
 
Cognitive functioning in dependent cocaine users 
Since the 1980s, researchers have endeavoured to examine the impact of chronic cocaine use on 
cognition, primarily by focusing on chronic and dependent cocaine users. The first broad quantitative 
review, conducted by Jovanovsky et al. (2005), included 15 empirical studies published between 1987 
and 2002, which incorporated cocaine users who met the DSM-III-R or DSM-IV criteria for cocaine 
abuse or dependence (n=481) and matched control groups (n=586 controls). Their results revealed that 
chronic cocaine use had strong effects on different measures of attention (Cohen’s d=0.40–1.10), 
moderate to strong effects on visual memory and working memory (d>0.50) and rather small effects 
on verbal fluency as well as other language and sensory-perceptual functions (d<0.30). Moreover, 
research pertaining to the heterogeneous concept of executive functioning revealed mixed findings, 
primarily depending on task requirements and difficulty levels. The major limitation of this review 
was the wide variety of abstinence periods in the analysed studies (0–1076 days). However, the mean 
abstinence time in the vast majority of the included studies was clearly more than three days, a time 
period that nowadays is commonly estimated to be relevant for acute and post-acute (withdrawal) 
effects of cocaine (Potvin et al., 2014). Insofar, the main results of Jovanovsky et al. (2005) can be 
interpreted as non-acute cognitive effects of cocaine use. 
 
Eight years later, Spronk et al. (2013) updated the review by Jovanovsky et al. (2005) by analysing 14 
studies on acute effects and 63 studies on long-term effects that were published between 2003 and 
2012. This was the first review that systematically distinguished between acute (defined as following 
cocaine administration in a laboratory setting) and long-term effects. Notably, long-term effects were 
broadly defined as effects in individuals with a history of cocaine use compared with cocaine-naive 
controls; a minimal abstinence time was not considered. Therefore, nearly half of the included studies 
on long-term effects had a minimal abstinence duration that was either unknown or less than three to 
four days. In addition,, Spronk et al. (2013) included seven preliminary and – with one exception 
(Rahman & Clarke, 2005) – relatively small studies on recreational cocaine users with sample sizes of 
n≤20. Given that 56 of the 63 reviewed studies focused on cocaine users with a diagnosed abuse or 
dependence, the main results of this systematic review might be more valid for chronic and dependent 
users than for occasional or recreational users. Despite these limitations, Spronk et al. (2013) reported 
– in agreement with the previous review by Jovanovsky et al. (2005) – that chronic cocaine use is 
characterised by broad cognitive impairments in the domains of attention and memory and various 
sub-processes of executive functions (impairments in reward-based decision-making and response 
inhibition, mild impairments in cognitive flexibility, indications for deficits in performance 
monitoring). 
A third systematic review, conducted by Potvin et al. (2014), considered the limitations of previous 
reviews by (a) including only studies with cocaine users who were diagnosed as abusers or dependents 
in accordance with DSM-criteria and (b) differentiating between short (positive urine screening), 
intermediate (≤12 weeks) and long-term (≥20 weeks) abstinence. This review included 1452 chronic 
cocaine users and 1411 controls from 46 studies (including 14 of 15 studies from the review by 
Jovanovski et al., 2005). In accordance with the two previously discussed reviews, the results of 
Potvin et al. (2014) suggest significant impairments across multiple cognitive domains for the 
intermediate abstinence duration. Again, attention (d=0.59) seemed to be more impaired than working 
memory (d=0.52) and some specific memory sub-domains (verbal/visual, learning/memory; d=0.43–
0.56). Moreover, some smaller deficits were found in a not-further-diversified executive functions 
domain (d=0.32). Furthermore, their results indicate that impairments were smaller after short-term 
abstinence than after intermediate abstinence, thus confirming some previous findings indicating that 
acute and residual cocaine effects influence cognitive functioning and mask some persisting 
neuropsychological decrements (Spronk et al., 2013). 
Whereas studies performed in the 1990s produced some ambiguous results, the more recent literature 
on dependent cocaine users draws a widely consistent picture of broad and relatively unspecific 
cognitive impairments in cocaine users. The rare inconsistencies within the recent publications are 
probably based on theoretical and methodological issues such as small sample sizes and different 
abstinence durations, as well as different cognitive domain definitions (notably, the executive function 
domain is still ill-defined, encompassing a wide range of concepts and tasks), psychiatric co-
morbidities and patterns/histories of cocaine or polydrug use. Moreover, as research has shown 
(Magura & Kang, 1996; Vonmoos et al., 2013), a considerable percentage of alleged cocaine users are 
probably not telling the truth about their actual drug use pattern and history. The lack of an objective 
verification of self-reported drug intake in most studies remains a major weakness in this research 
field. However, within the framework of the large Zurich Cocaine Cognition Study (ZuCo2St), in 
which urine and hair toxicology analyses were performed to characterise objectively not only recent 
drug use but also drug use over the past six months, Vonmoos et al. (2013) confirmed the results of the 
current literature in a large cross-sectional analysis by describing broad cognitive impairments in 30 
dependent cocaine users (Figure 1). Again, their results demonstrated that impairments were not 
specific; that is, they affected all investigated cognitive domains – attention, working memory, 
declarative memory and executive functions – with moderate to large effect sizes (d=0.74–1.00) 
(Figure 2).  
 
Cognitive functioning in recreational/occasional cocaine users 
Whereas most studies have focused on the dependent use of cocaine, only limited research has 
systematically investigated the cognitive effects of only occasional or recreational drug intake on non-
dependent cocaine users. However, as this user group accounts for the majority of cocaine users 
(Anthony, 2002; EMCDDA, 2015), potential cognitive changes yield higher ecological validity and 
are, thus, especially interesting with regard to prevention efforts. Compared with research on 
dependent cocaine users, the analysis of this non-dependent user group has provided evidence of not 
only some considerable advantages but also some additional barriers. On the one hand, recreational 
cocaine users are – as data from our ZuCo2St have shown – generally less burdened by psychiatric co-
morbidities and polytoxic drug use (Quednow, 2016). Moreover, because recreational cocaine use can 
be considered an intermediate step towards addiction (Gould, 2010), the separate analysis of non-
dependent users allows a clear distinction between aspects specifically related to addiction and those 
presumably related to occasional use. On the other hand, there is currently no standard classification of 
recreational cocaine use. Whereas cocaine abuse and dependency are still diagnosed based on the 
DSM-IV criteria – or, recently, are based on substance use disorder symptoms in DSM-V – the current 
literature continues to provide different definitions of recreational cocaine use, with most definitions 
based on the recent consumption pattern. Additional barriers to the comparability of studies with 
recreational cocaine users (similar to those barriers described in the studies on dependent users) are the 
variations in the minimal abstinence periods (ranging from two days to two weeks) and the mostly 
missing objective toxicology measures. Although the different definitions might pose a problem with 
regard to the comparability of these studies, one should keep in mind that the majority of the studies 
on recreational cocaine use shared two important features: these studies usually required recreational 
users to have a certain minimal use of cocaine in the last month (≥0.5g) and not explicitly meet the 
previously mentioned DSM-IV criteria for cocaine dependence.  
The limited literature available, consisting of studies with mostly small and sometimes overlapping 
samples of recreational cocaine users, indicates that already small and infrequent doses of cocaine 
affect different cognitive components. More specifically, the published studies described deficits in 
attention, visuospatial perception, components of verbal memory (Rahman & Clarke, 2005), inhibitory 
behavioural control (Colzato et al., 2007), scope of visual attention (Colzato et al., 2009b), cognitive 
flexibility but not working memory (Colzato et al., 2009a), control of saccadic eye-movement 
(inhibition-of-return) (Colzato & Hommel, 2009), sustained attention, attentional shifting, spatial 
memory (Soar et al., 2012), cognitive control in the sense of conflict management (Sellaro et al., 2014) 
and inhibitory attentional processes (Soar et al., 2015). Furthermore, recreational stimulant users with 
cocaine as the primary drug of use showed memory performance deficits in verbal learning, recall and 
recognition domains (Reske et al., 2010). Recently, Vonmoos et al. (2013) investigated the largest 
sample of recreational cocaine users (n=68) to date; in addition, this sample was the only one thus far 
to undergo urine and six-month hair toxicology analyses as objective measures of cocaine use 
intensity. The results of this study were consistent with the previous literature suggesting considerable 
and broad and widely unspecific cognitive impairments even in recreational users. Vonmoos et al. 
(2013) reported that similar to dependent users, recreational users exhibited significant impairments in 
the domains of attention, working memory, memory and executive functions, all with moderate effect 
sizes (d=0.39–0.44). However, in all four domains, recreational cocaine users performed 
intermediately between controls and dependent users (Figure 2). 
 
Relationship between the severity of cocaine use and cognitive functioning 
In summary, the aforementioned findings suggest that the cognitive performance differences between 
recreational and dependent users reflect either a qualitative difference between the two user groups 
(addicted vs. non-addicted) or a dimensional relationship between the severity of cocaine use and 
cognitive impairments. The latter hypothesis is supported by the fact that several studies have found 
negative correlations between cognitive performance and the severity of cocaine use, as, for example, 
measured by dose of cocaine (g/week) (Bolla et al., 2000; 1999), cumulative cocaine dose, duration of 
cocaine use and cocaine metabolites in hair (Vonmoos et al., 2013). These dose-response relationships 
have been further confirmed by an increased risk of cognitive impairment at increasing cumulative 
doses of cocaine (Vonmoos et al., 2013). Whereas a lifetime consumption of >10g was associated with 
a ~50% risk for mild cognitive impairment (below -1 standard deviations from the mean of the 
controls), this risk increased to approximately two thirds for those with a lifetime use >500g and, even 
further, to 75% for those with a cumulative lifetime dose of >1kg (Figure 3). 
As investigated in a cross-sectional study design, these results suggest that cognitive impairments 
might be at least partially cocaine-induced (Vonmoos et al., 2013). These findings are in line with 
previous studies on chronic cocaine self-administration in rhesus monkeys, which also suggested that 
some alterations in cognitive functioning might be cocaine-induced (Gould et al., 2012; Porter et al., 
2011). 
 
Cocaine-induced cognitive deficits are drug-induced and partially reversible 
Even though the cross-sectional literature initially suggested that deficits in cognitive functioning 
might be at least partially cocaine-induced, longitudinal studies are needed to support this hypothesis. 
Moreover, the reversibility of cognitive dysfunction can be investigated only with longitudinal study 
designs. As longitudinal studies are very costly and time-consuming, there are currently only a few 
studies that have investigated cognitive changes in cocaine users over longer time periods.  
To date, we are aware of five cross-sectional (Bolla et al., 1999; De Oliveira et al., 2009; Di Sclafani 
et al., 1998; Rosselli & Ardila, 1996; Rosselli et al., 2001) and four longitudinal studies (Bauer, 1996; 
Bolla et al., 2000; Di Sclafani et al., 2002; van Gorp et al., 1999) investigating the effect of long-term 
abstinence (≥1 month) on cognition in cocaine users. Most of the studies with short abstinence periods 
suggested stable and persistent cognitive impairments; however, the two studies with the longest 
abstinence durations – six months (Di Sclafani et al., 2002) and longer (De Oliveira et al., 2009) – 
both suggested cognitive recovery for abstinent cocaine users with regard to working memory (Di 
Sclafani et al., 2002) and verbal declarative memory (De Oliveira et al., 2009). Whereas Di Sclafani et 
al. (2002) themselves critically noted that they could not confirm such improvements for any other 
domain and therefore speculated that these working memory improvements might be based on practice 
effects, De Oliveira et al. (2009) suggested that some of their presented recovery effects could indeed 
have been caused by abstinence, thus indicating the reversibility of cognitive deficits. Accordingly, the 
aforementioned review by Potvin et al. (2014) analysed five studies on cocaine users with abstinence 
periods ≥20 weeks and indicated that cognitive impairments remain stable during the first few months 
of abstinence but probably dilute after some months. 
The clearest limitations of the long-term abstinence studies cited here were (a) the general lack of 
toxicological verifications of cocaine use and abstinence periods (most studies performed no 
toxicology tests or only random urine screenings), (b) the sometimes very rudimentary information on 
the severity of previous drug use and (c) the relatively brief follow-up intervals. Furthermore, these 
studies focused exclusively on cocaine users who ceased their consumption, and until recently, there 
were no published analyses investigating the cognitive development in individuals who increased their 
cocaine consumption. Vonmoos et al. (2014) were the first to investigate the relationship between 
changes in the intensity of cocaine use and the development of cognitive functioning. Their sample 
was tested twice with a one-year interval between testing, and the intensity of cocaine use was 
objectively determined by quantitative six-month hair toxicology analyses. The analyses of hair 
cocaine concentrations revealed that one third of users (n=19) displayed strongly increased cocaine 
levels (mean +297%, mean cocaine concentration +30.4 ng/mg, SD 61.9 ng/mg), one third (n=19) 
showed substantially decreased concentrations (−72%, −10.6 ng/mg, SD 26.7 ng/mg) and one third 
(n=19) had not changed their consumption pattern. However, the stable user group included rather 
moderate users with much lower cocaine contamination in hair compared with the other two user 
groups (Vonmoos et al., 2014). In this study, substantially increased cocaine use within one year led to 
further cognitive performance deterioration, foremost in the working memory. By contrast, and as 
expected from the previously mentioned studies by Di Sclafani et al. (2002) and De Oliveira et al. 
(2009), decreased cocaine use generally improved cognition and showed the strongest enhancements 
in working memory and declarative memory. Moreover, of the 19 decreasing users, eight did not reach 
a commonly accepted hair cocaine concentration cut-off of 0.5 ng/mg at follow-up (Cooper et al., 
2012), and, thus, they were considered to have been abstinent for at least three to six months. All these 
eight ceasing users seemed to recover completely and attained a cognitive performance level 
comparable to that of the controls (Figure 4). As this abstinent user group reported a cumulative 
cocaine lifetime dose of 700 g on average, it reached a lifetime dose amount that has been previously 
shown to increase the risk for cognitive impairment clearly (Vonmoos et al., 2013). However, it 
remains unclear whether there is a ‘point of no return’ beyond which a full recovery cannot be 
expected.  
 
Confounding and moderating factors 
Given that cocaine use is frequently associated with symptoms of attention-deficit hyperactivity 
disorder (ADHD) (Wilson, 2007) and depression (Swendsen & Merikangas, 2000), it should be noted 
that both co-morbidities are also important modulators of cognitive functioning in cocaine users 
(Vonmoos et al., 2013). Recent research studies found that the combination of ADHD and cocaine 
consumption seemed to have a cumulative aggravation of detrimental effects on cognitive 
performance (Vonmoos et al., 2013; Wunderli et al., 2016). By contrast, only a weak additive impact 
of depressive symptoms on cognitive performance was found in recreational users, but not in 
dependent users (Vonmoos et al., 2013).  
Another important modulator for cognitive functioning seems to be the age-of-onset of cocaine use. 
Individuals who started their cocaine consumption before the age of 18 years showed stronger 
cognitive impairments than users with a later onset – even when the data were adjusted for duration of 
use or age (Vonmoos et al., 2013). Moreover, the longitudinal analysis showed that early onset of use 
was associated with reduced recovery of working memory when the cocaine use was decreased 
(Vonmoos et al., 2014). In summary, these data suggest that early onset of cocaine use might be a risk 
factor for sustained cognitive impairment following chronic cocaine use.  
 
Social cognition 
Another important aspect of cognitive functioning that is quite relevant in different mental disorders 
(including cocaine addiction) is social cognition (Verdejo-Garcia, 2014). Given that social problems 
are well known in drug users and that socio-cognitive abilities have been demonstrated to play 
important roles in psychiatric disorders such as depression (Weightman et al., 2014) and schizophrenia 
(Couture et al., 2006), it was analogously proposed that social cognition and interaction may also play 
essential roles in the origin and course of drug addiction (Volkow et al., 2011). Until recently, 
systematic and experimental investigations broadly characterising and quantifying social cognition and 
interaction in cocaine users had been rarely explored, however. Before the finalisation of the ZuCo2St 
(Quednow, 2016), only two studies have thus far described impaired fear recognition accuracy in 
recreational users (Kemmis et al., 2007) and emotional intelligence deficits in dependent cocaine users 
(Fox et al., 2011). The ZuCo2St, which started in January 2010, was the first study to examine social 
cognition and interaction in recreational and dependent cocaine users in depth. In contrast to the 
findings of the two previous studies, the ZuCo2St findings did not replicate the deficits in cocaine 
users in emotion perception and recognition when the stimulus material was visual (faces, complex 
scenes) (Preller et al., 2014b). However, the cocaine users in the ZuCo2St had problems correctly 
recognising the emotion from voices (prosody) and correctly linking simultaneously presented 
emotional faces and voices. Notably, longer duration and higher cumulative cocaine use were 
negatively correlated with the integration of visual and facial emotions, indicating that not only basal 
cognitive but also social cognitive problems of cocaine users might be at least partially drug-induced 
(Hulka et al., 2013). Both recreational and dependent cocaine users displayed impairments in 
emotional empathy, whereas only dependent users (not recreational users) revealed impaired mental 
perspective-taking (also called theory-of-mind), which was correlated with the severity of cocaine 
intake (Preller et al., 2014b).  
In summary, these findings indicate disturbed emotional information integration in chronic cocaine 
users. Research also indicates a linkage between cocaine users’ impairments in social cognition tasks 
and altered social reward processing (2014a). Taken together, these findings indicate that social 
cognition impairments in cocaine users are closely related to their real-life social functioning. 
Consequently, their general social competence might become impaired and promote antisocial 
behaviour ranging from decreased social contact to increased criminal behaviour (Preller et al., 2014a; 
2014b). 
 
Neurobiological linkage between cocaine use and cognitive functioning 
Although there is increasing support for cocaine-related cognitive alterations, the exact underlying 
neurobiological substrates remain unclear (Cadet & Bisagno, 2016). Adaptations involving the 
monoamine systems are most likely to occur as cocaine acts as an unspecific monoamine transporter 
blocker with high affinity for dopamine, serotonin and norepinephrine transporters (Ritz et al., 1990). 
Mainly owing to the higher availability of reliable radiotracers for the dopamine system, molecular 
imaging evidence has initially accumulated showing that addictive cocaine use leads to neuroadaptive 
changes in dopamine receptors and transporters in the fronto-striatal network (Hu et al., 2015; Volkow 
et al., 2004). Consequently, researchers have proposed that these changes in the dopamine system 
represent the common denominator of the broad cognitive impairments in cocaine users (Garavan & 
Hester, 2007). However, molecular imaging studies investigating alterations in the serotonin and 
noradrenaline system in cocaine users are lacking, with one exception: a single positron emission 
tomography study has shown that norepinephrine transporter density in the thalamus is upregulated in 
cocaine users (Ding et al., 2010). In line with a recent publication demonstrating that increased delay 
discounting in cocaine users might be explained by an interaction between a genetic variation of an 
alpha-adrenergic receptor and cocaine use (Havranek et al., 2016), this finding suggests that 
adaptations in the norepinephrine system might also account for some cognitive changes found in 
cocaine users. Another recent study indicates that genetic variation in serotonin transporters also plays 
an important role in the development of working memory deficits in chronic cocaine users (Havranek 
et al., 2015); thus, changes in the serotonin system might be involved in cocaine-related cognitive 
impairments. Gaining greater insight into the various changes in the monoamine neurotransmitter 
systems may help explain the broad cognitive impairments of cocaine users, which are somewhat 
different from the more distinct cognitive deficit profiles in chronic users of other substances such as 
ecstasy, amphetamine and opiates (van Holst & Schilt, 2011).  
In addition, acute cocaine intake is associated with a strongly increased risk of cerebrovascular 
complications, such as haemorrhagic and ischaemic stroke (Treadwell & Robinson, 2007), which 
often result in chronic cognitive dysfunctions (Lesniak et al., 2008). However, cognitive deficits are 
also observed in cocaine users without a history of strokes (Vonmoos et al., 2013).  
 
Conclusion 
The current literature suggests that the broad cognitive deficits in cocaine users might be at least 
partially drug-induced, and some promising results further indicate that they are potentially reversible, 
at least after moderate exposure and late onset of use. In addition to basal cognitive deficits, chronic 
cocaine users suffer from socio-cognitive and psychosocial impairments (Cadet & Bisagno, 2016). 
However, there is still no clarity on the relationship between the extent of cocaine use and the 
development of different aspects of cognitive impairment. The decoding of this specific relationship is 
complex because (a) there exist some fundamental inconsistencies regarding study designs and sample 
characteristics (e.g. severity of use, polydrug use, psychiatric co-morbidities, main route of 
administration) in the current literature and (b) there are some potentially relevant modulating factors 
(e.g. purity of the drug, lifestyle differences, genetic predispositions, environmental factors), which are 
often hard to consider and have rarely been systematically investigated thus far. However, breaking 
down these factors is important for the personal, public and clinical management of cocaine addiction. 
Particularly because there is still no effective pharmacological treatment for cocaine addiction, this 
research provides some helpful insights and implications with regard to the development of effective 
prevention and intervention processes. First, basal and social cognitive functioning are closely related 
to real-life functioning and, thus, are of relevance in the daily lives of users (Garavan & Hester, 2007; 
Preller et al., 2014b; Verdejo-Garcia, 2014; Volkow et al., 2011). Second, the indicated relevance of 
an early age-of-onset and the limited cognitive capacity of the target group suggest that the best way to 
tackle cocaine addiction is through prevention in an early, non-dependent stage of use and through 
simplified education that aims to suppress the motivational impact of drug cues. Third, in recent years, 
mounting evidence has suggested that cognitive impairments decrease treatment compliance and 
retention in cocaine-dependent patients (Aharonovich et al., 2006; Streeter et al., 2008). Additionally, 
Bickel et al. (2011) demonstrated that cognitive training of working memory decreases delay 
discounting, a fundamental feature of cocaine addiction (Hulka et al., 2014). Garcia et al. (2005) also 
reported that working memory and executive functions are related to more adaptive cognitive 
explanatory styles. Likewise, studies have shown cognitive remediation therapies to be beneficial in 
the treatment of other – closely related and highly co-morbid – psychiatric disorders such as 
schizophrenia (Green, 2005; Wykes et al., 2011), depression (Elgamal et al., 2007; Swendsen & 
Merikangas, 2000) and ADHD (O'Connell et al., 2006; Wilson, 2007). Fourth, the fact that even 
chronic cocaine use does not necessarily lead to irreversible cognitive deficits might be a finding with 
an enormous impact on the motivation of affected individuals to seek treatment for their addiction.  
In light of the discovery of a robust cognitive profile of cocaine users and some preliminary results 
clearly indicating a cocaine-induced variability in cognitive performance, the next challenge is 
doubtlessly to clarify (a) the exact pattern and interaction of cognitive effects and their causal 
relationship with addiction (Garavan & Hester, 2007) and (b) the role of other potentially relevant 
factors (in addition to cocaine) that might have a pivotal impact on cognitive functioning. 
Mini-Dictionary of Terms 
• Cognitive functioning: The individual functional properties regarding a broad range of basal 
mental operations (i.e. attention, memory, executive functions). 
• Emotional empathy: The ability to feel and share the emotions of others. 
• Executive functions: Heterogeneous concept of complex cognitive functions usually involving 
the frontal cortex (inhibition, flexibility, monitoring, rule acquisition, planning etc.).  
• Social cognition: Mental operations to understand oneself and others. 
• Theory-of-mind: The attribution of emotions, intentions and goals to others, also known as 
emotional and mental perspective-taking. 
 
Key Facts of Attention-deficit/hyperactivity disorder  
• ADHD is characterised by a persistent pattern of inattention and/or hyperactivity-impulsivity.  
• In DSM-V, ADHD is divided into 3 subtypes: predominantly inattentive, predominantly 
hyperactive/impulsive, and combined. 
• ADHD symptoms may contribute to the development of substance use disorders, and, vice 
versa, substance use can adversely affect these symptoms (Wilson, 2007). 
• The prevalence  of  adult ADHD  in  chronic  cocaine  users  is  higher  than in  the  general  
population (Wunderli et al., 2016). 
• Cocaine  users  with  ADHD  show  stronger  cognitive  impairments  than  cocaine  users  
without  ADHD  (Vonmoos et al., 2013; Wunderli et al., 2016). 
 
Summary Points 
• Recreational and dependent cocaine users display broad cognitive and socio-cognitive 
impairments. 
• Cognitive dysfunctions in cocaine users are positively correlated with several subjective and 
objective drug-intake parameters and also co-vary with changing cocaine use. 
• Cognitive impairments in cocaine users seem to be partially drug-induced and reversible. 
• Age-of-onset of cocaine use is an important factor in cognitive impairment and recovery. 
• Cognitive impairments associated with cocaine use are potentially caused by monoaminergic 
adaptations in the fronto-striatal network. 
 
  
Figure legend 
Title Figure 1: Global cognition in controls, recreational, and dependent cocaine users. 
 
Legend Figure 1: Global cognition scores separated for control group (n=68), recreational 
cocaine user group (n=68), and dependent cocaine user group (n=30). The dotted grey line 
represents the mean of the control group. The dotted black line represents the clinical criterion 
of -1 standard deviation of the control group (-.54; value corrected for age and verbal IQ). 
From Vonmoos et al. (2013) with permission from The Royal College of Psychiatrists. 
 
 
 
Title Figure 2: Cohen’s d effect sizes of cognitive test scores and cognitive domains in 
recreational and dependent cocaine users versus controls. 
 
Legend Figure 2: Cohen's d values of recreational and dependent cocaine users compared 
with the control group. Data based on the z-scores (values corrected for age and verbal IQ) as 
reported in Vonmoos et al. (2013) with permission from The Royal College of Psychiatrists. 
RVP: Cantab Rapid Visual Processing, SWM: Cantab Spatial Working Memory, IED: Cantab 
Intra/Extradimensional Set Shifting, PAL: Cantab Paired Associates Learning, RAVLT: Rey 
Auditory Verbal Learning Test, LNST: Letter Number Sequencing Task. According to 
theoretical a priori considerations, the 15 test parameters were z-transformed on the basis of 
means/standard deviations of the control group and reduced to the four domains. Global 
cognition was calculated by equally integrating the four domains (for details see Vonmoos et al., 
2013). 
 
 
 
Title Figure 3: Relationship between lifetime use of cocaine and the risk for cognitive 
impairment.  
 
Legend Figure 3: (a) Percentage of chronic cocaine users fulfilling the clinical cognitive 
criterion of below -1 standard deviation (-.54; value corrected for age and verbal IQ) in the 
specific cumulative dose group. (b) Percentage of chronic cocaine users fulfilling the clinical 
cognitive criterion of below -1 standard deviation in groups with from left to right ascending 
cumulative lifetime doses of cocaine. From Vonmoos et al. (2013) with permission from The 
Royal College of Psychiatrists. 
 
 
 
Title Figure 4: Cognitive functions in low/high cocaine increasers and decreasers with 
ongoing/ceased cocaine use within one year.  
 
Legend Figure 4: Change in global cognition score from the baseline (t1) to the one-year 
follow-up (t2). Follow-up values were adjusted for the test-retest effect. Mixed Ancova 
(corrected for ADHD) group*time interaction (F3,33=1.70, p=.19, pη2=.13). Sidak post-hoc 
tests (*p<.05). GCI: increaserlow p=.61, d=-0.14, increaserhigh p=.41, d=-0.30, decreaserongoing 
p=.82, d=0.06, decreaserceasing p<.05, d=0.93. From Vonmoos et al. (2014) with permission from 
Nature Publishing Group. 
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